MedPath
NMPA Approval

Neostigmine Methylsulfate Injection

国药准字H20249616

December 1, 2024

Drug Information

甲硫酸新斯的明注射液

注射剂

1ml:0.5mg

化学药品

December 1, 2024

Company Information

Applicant Company

浙江省金华市东阳市江北街道猴塘社区广福东街23号总部中心B幢东楼502-1室

Manufacturing Company

浙江省东阳市江北高科技工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath